Autolus Ltd.

Autolus Ltd.

Autolus Ltd.

Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered Tcell immunotherapy products with extreme efficacy in the treatment of lifethreatening cancers..
Type
B2b
Founded
2014
Raised
$285.6M
Follow us
Alexa global traffic share
22 Jun 2018
26 Sep 2017
$80,000,000
Venture capital (Series C)
03 Mar 2016
£40,000,000
Venture capital (Series B)
woodfordfunds, Perceptive Bioscience

UCL spin-out Autolus secures £40 million funding

Academic publication